By Admin at 13 Oct 2017

When Carol Ramnarine was diagnosed with multiple myeloma, a rare cancer of plasma cells (a type of white blood cell in bone marrow), she was offered the chance to take part in a clinical trial run by Dr. Jeffrey Wong at City of Hope cancer treatment and research center in southern California.

By Admin at 23 May 2016

Gateway has just approved two new immunotherapy trials. A brain cancer study at MD Anderson will assess if immunotherapy can target a virus (cytomegalovirus or CMV) that is commonly found in Glioblastoma cancer cells but not in normal brain tissue. And, a pancreatic cancer study at Johns Hopkins will assess the effectiveness of combining five treatment modalities (including the promising new drug Pembrolizumab) on patients with aggressive and deadly advanced pancreatic adenocarcinoma.

By Admin at 13 Apr 2016

Patients with acute lymphoblastic leukemia (ALL), non-Hodgkin lymphoma and chronic lymphocytic leukemia are taking part in the trial and received an experimental “living” immunotherapy. The results have so far been “extraordinary,” according to the researchers, including among some patients that were initially given only months to live.

By Admin at 23 Oct 2015

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, and although survival rates vary from two to 20 years after diagnosis, it is considered incurable with conventional therapies. While stem cell transplants may provide a cure, not all patients are eligible for the procedure, which is why a new experimental therapy, called CTL019, is raising hope for many.